Latest Sustainable Growth News

OFX Group Limited’s half-year results reveal a sharp 78% drop in statutory net profit to $2.4 million, driven by lower fee and trading income and rising expenses. The company is advancing its New Client Platform rollout and has initiated a new share buy-back program to support growth and capital management.

Associate Global Partners Limited (AGP) reported robust FY25 results, with funds under management climbing to $1.464 billion, driven by stellar investment returns and successful capital raisings. The firm is advancing its distribution reach and launching new products to sustain momentum.

Altair Minerals has raised A$13 million through an institutional placement led by 1832 Asset Management, fully funding an extensive drilling program at its Greater Oko Project set to begin early next year.

Gibb River Diamonds has commenced mining at its Neta Gold Prospect in WA, with ore processing agreements in place and first cashflow anticipated by early 2026. The company also outlines ambitious exploration plans for its broader portfolio.

NRW Holdings showcased strong FY25 proforma results and ambitious FY26 guidance at the UBS Conference, underpinned by strategic acquisitions and a diversified portfolio. The company’s growth strategy focuses on expanding capabilities in energy transition and infrastructure markets across Australia, New Zealand, and North America.

DroneShield has secured a $7.6 million contract for handheld counterdrone systems from the U.S. Government, marking another repeat order that underscores its expanding footprint and production scale-up.

Iress launches a comprehensive FY26 business efficiency program targeting a 25% cash EBITDA margin, while narrowing its FY25 guidance and welcoming a new CEO.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Count Limited reported robust FY2025 growth with funds under management surpassing $5.1 billion and increased dividends, while advancing its acquisition strategy and embracing AI-driven efficiencies.

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

Epsilon Healthcare has posted its highest-ever quarterly receipts of $2.919 million, reflecting a robust turnaround since exiting voluntary administration in mid-2024. The company’s strategic sale and leaseback deal has also enabled significant debt reduction, setting the stage for sustained growth.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.